Elsevier, a global leader in information and analytics, is announcing the addition of half a million records from ClinicalTrials.gov to its leading biomedical literature database, Embase. The integration will enable researchers to seamlessly view high-quality information on clinical research studies and their results alongside the peer-reviewed literature, in-press publications and conference abstracts already available in Embase. Continue reading
May 1, 2025 /Mpelembe Media/ — A new online survey conducted by The Harris Poll on behalf of Alkermes, Inc., a biopharmaceutical company focused on neuroscience, explores the experiences of individuals diagnosed with Alcohol Use Disorder (AUD). Continue reading
GammaPod represents a true revolution in the treatment of breast cancer: it allows the safe and precise administration of high doses of radiation to the tumor because, unlike conventional radiotherapy equipment, designed to treat tumors in all areas of the body, GammaPod was invented and designed to treat only breast cancer. Continue reading
Jan. 3, 2025 /Mpelembe Media/ — The Surgeon General of the U.S. has called for cancer warnings on alcoholic beverages, citing studies linking alcohol consumption to at least seven types of cancer. A recent review of research supports this, showing a correlation between higher alcohol intake and increased cancer risk, particularly breast cancer. Continue reading
Diseases are best fought when those in the high-risk bracket understand as to what are the risk factors involved. It is true that you cannot avoid the genetic factor but you can still keep the situation in your control by making a few changes in your current approach to life and living. Continue reading
ONE® Flex® Condoms, the world’s first condom enhanced with the wonder material graphene, is now available at select Walmart stores and Walmart.com. Building on its online sales success since its market debut in October 2023, ONE Flex is further expanding its reach by bringing this revolutionary condom technology to Walmart shoppers. Continue reading
Orbis International announces new research that finds telemedicine can improve care for children with retinoblastoma, a form of childhood cancer that can lead to blindness. The study, published in JCO Global Oncology, is the first to show that virtual mentor-mentee relationships through Cybersight, Orbis’s free telemedicine and e-learning platform, not only improves lives, but can save them by successfully transferring skills to eye care professionals in low- and middle-income countries. Continue reading
After the fall of the al-Assad regime in Syria, large stockpiles of the illicit drug captagon have reportedly been uncovered.
We all know drug and alcohol addiction occurs. We also know some people can use and not get addicted. We all know that they are both injurious to our health. Then why is it that the addiction to drugs and alcohol is increasing everyday? Why do people still destroy their lives and family? Is drug and alcohol addiction a matter of will power, choice or is it a disease?
Let’s examine these questions in detail. Continue reading
International oncology experts are gathering in Accra, Ghana for a series of meetings beginning today, to update cancer treatment recommendations in the NCCN Harmonized Guidelines™ for Sub-Saharan Africa. This is the latest event from a longstanding collaboration between the African Cancer Coalition (ACC), American Cancer Society (ACS), and National Comprehensive Cancer Network® (NCCN®), and the Clinton Health Access Initiative (CHAI) that collectively form the group Allied Against Cancer. Together, the organizations are focused on providing context-appropriate, evidence-based cancer care strategies that address the unique challenges faced across the region. Continue reading